Valuation CellaVision AB OTC Markets
Stocks
CLVSF
SE0000683484
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.00 USD | +3.78% |
|
-.--% | -16.80% |
| 07-20 | Danske Bank raises Cellavision target price to 187 kronor (180), reiterates buy - BN | FW |
| 07-20 | DNB Carnegie raises price target for Cellavision to 180 kronor (175), reiterates buy | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,530 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | -5.85% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,343 | 3,308 | 3,252 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | -6.81% | -1.03% | -1.71% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 25.4x | 20.2x | 17.8x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 3.65x | 3.31x | 2.98x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -2.77x | 0.8x | 1.3x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 4.55x | 4.06x | 3.74x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 4.31x | 3.8x | 3.44x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 14.7x | 11.9x | 10.5x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 18.8x | 14.8x | 12.8x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 31x | 29.5x | 23.3x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 3.23% | 3.39% | 4.29% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.133 | 3.4 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.86% | 2.12% | 2.3% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.831 | 7.313 | 8.294 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.2% | 42.8% | 41% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 775.1 | 870 | 944.7 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.3 | 277.7 | 309.5 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 177.5 | 222.9 | 253.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 139 | 174.4 | 197.7 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -187.5 | -221.9 | -278.4 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 148.00 | 148.00 | 148.00 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 59.14x | 4.62x | 15.48x | 0.36% | 16.23B | |
| 41.25x | - | - | 1.96% | 1.85B | |
| -10.48x | 1.3x | 5.7x | -.--% | 1.21B | |
| 16.37x | 2.31x | 7.74x | 1.43% | 972M | |
| 53.08x | - | - | 0.84% | 540M | |
| 48.13x | - | - | - | 502M | |
| 18.1x | 2.55x | 10.88x | 1.88% | 390M | |
| -13.2x | - | - | - | 345M | |
| Average | 26.55x | 2.69x | 9.95x | 1.08% | 2.75B | |
| Weighted average by Cap. | 49.68x | 4.24x | 14.35x | 0.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- CLVSF Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
